Antonio Llombart-Cussac, José Manuel Pérez García, Elena López-Miranda, Cristina Saavedra, Vicente Carañana, Isabel Blancas, Carmen Hinojo González, Alfonso Cortes-Salgado, Elena Galve Calvo, Rui Rui Zhang Xiang, Daniel Alcalá-López, Juliana Carvalho Santos, Olga Boix, Ana Garrido, Carlos H. Barrios, Giuseppe Curigliano, Rupert Bartsch, Anne-Claire Hardy-Bessard, Tomer Wasserman, Javier Cortés. "ADELA: A double-blind, placebo-controlled, randomized phase 3 trial of elacestrant (Ela) + everolimus (EVE) versus elacestrant + placebo in ER+/HER2− advanced breast cancer (aBC) patients with
                    <i>ESR1</i>
                    -mutated tumors progressing on endocrine therapy (ET) + CDK4/6i.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1154